J. R. Curtis, D. Elewaut, S. Chen, M. Hojnik, N. Naveh, and J. K. Anderson, “Incidence of Inflammatory Bowel Disease Events in Adalimumab Clinical Trials Across Indications”, J of Skin, vol. 1, no. 3.1, p. s18, Oct. 2017.